奧鋭特(605116.SH):公司8277萬元競得一幅地塊並簽署合同
格隆匯1月11日丨奧鋭特(605116.SH)公佈,近日,公司參加了在浙江省土地使用權網上交易系統進行的國有建設用地使用權掛牌出讓活動,以總價8277.00萬元人民幣競得天台縣蒼山產業聚集區TDB01-0303、0304地塊的國有建設用地使用權,出讓面積為12.54萬平方米,並於2021年1月8日持《成交確認書》與天台縣自然資源和規劃局簽署了《國有建設用地使用權出讓合同》。公司本次購買上述地塊的使用權,主要目的是為了促進公司的轉型升級,提高裝備水平,進一步提高核心競爭力,符合公司整體發展佈局,為公司可持續發展提供基礎保障。不會對公司未來財務狀況和經營成果產生重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.